Cagrilintide  is a synthetic long-acting analog of the naturally occurring hormone amylin. Laboratory research involving Cagrilintide explores its potential effects on appetite regulation, energy balance, and weight management. Studies suggest that Cagrilintide may modulate satiety signals and gastrointestinal motility, influencing food intake and energy consumption pathways.

Scientific investigations are actively examining Cagrilintide’s potential impacts on metabolic processes, particularly related to obesity, appetite control, and energy homeostasis in laboratory settings.

Important Notice:  This product is intended strictly for research purposes only. It is not approved by the FDA and is not intended for human or animal consumption, nor for diagnostic, therapeutic, or clinical applications. Usage of Cagrilintide outside laboratory research settings violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. §§ 355(a) and 331(d).

Purity: ≥99% (HPLC verified)

Formulation: Lyophilized powder

Molecular Formula: C171H267N51O53

Molecular Weight: 3955.3 g/mol

CAS Number: 1222316-42-2

Important Notice:This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.